Yu W - Search Results

1

Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience.

Yu W, Mao L, Qian J, Qian W, Meng H, Mai W, Tong H, Tong Y, Jin J. Yu W, et al. Ann Hematol. 2013 Aug;92(8):1091-100. doi: 10.1007/s00277-013-1758-5. Epub 2013 Apr 18. Ann Hematol. 2013. PMID: 23595277 Clinical Trial.

2

[Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].

Mi YC, Xue YP, Yu WJ, Liu SH, Zhao YZ, Meng QX, Bian SG, Wang JX. Mi YC, et al. Zhonghua Xue Ye Xue Za Zhi. 2005 Dec;26(12):705-9. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 16620570 Chinese.

3

Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype.

Mi Y, Xue Y, Yu W, Liu S, Zhao Y, Meng Q, Bian S, Wang J. Mi Y, et al. Among authors: yu w. Leuk Lymphoma. 2008 Mar;49(3):524-30. doi: 10.1080/10428190701836852. Leuk Lymphoma. 2008. PMID: 18297530

4

Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.

Liu J, Mi Y, Fu M, Yu W, Wang Y, Lin D, Bian S, Wang J. Liu J, et al. Among authors: yu w. Am J Hematol. 2009 Jul;84(7):422-7. doi: 10.1002/ajh.21441. Am J Hematol. 2009. PMID: 19484734 Free article.

5

Bortezomib in treatment of extramedullary plasmacytoma of the pancreas.

Wei JY, Tong HY, Zhu WF, Liu H, Zhang FJ, Yu WJ, Jin J. Wei JY, et al. Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):329-31. Hepatobiliary Pancreat Dis Int. 2009. PMID: 19502179

6

Mantle cell lymphoma in a mother and her daughter.

Qian J, Xiao C, Yu W, Wang H, Jie J. Qian J, et al. Among authors: yu w. Leuk Lymphoma. 2011 Apr;52(4):726-7. doi: 10.3109/10428194.2010.542597. Epub 2011 Jan 28. Leuk Lymphoma. 2011. PMID: 21275634 No abstract available.

7

Heat shock protein 90 inhibition results in altered downstream signaling of mutant KIT and exerts synergistic effects on Kasumi-1 cells when combining with histone deacetylase inhibitor.

Yu W, Wang J, Jin J, Qian W, Qian J, Cheng Y, Wang L. Yu W, et al. Leuk Res. 2011 Sep;35(9):1212-8. doi: 10.1016/j.leukres.2011.05.014. Epub 2011 May 31. Leuk Res. 2011. PMID: 21632108

8

[ITF-2357 on inhibition myeloid leukemic cell lines cells proliferation in vitro and its mechanism].

Yu WJ, Wang L, You LS, Mei C, Ma QL, Jin J. Yu WJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):366-70. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22781793 Chinese.

9

Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy.

Lou Y, Suo S, Tong Y, Tong H, Qian W, Meng H, Mai W, Huang J, Yu W, Jin J. Lou Y, et al. Among authors: yu w. Ann Hematol. 2014 Jun;93(6):941-8. doi: 10.1007/s00277-013-2000-1. Epub 2014 Jan 10. Ann Hematol. 2014. PMID: 24408159

10

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.

Lu S, Xu Y, Mu Q, Cao L, Chen J, Zhu Z, Lou Y, Meng H, Qian W, Tong H, Mai W, Huang J, Yu W, Zhao X, Jin J. Lu S, et al. Among authors: yu w. Leuk Lymphoma. 2015 Apr;56(4):1027-32. doi: 10.3109/10428194.2014.947606. Epub 2014 Aug 19. Leuk Lymphoma. 2015. PMID: 25065698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,248 results

Search Page